BSE filing, NSE: KAMDHENU. Summary written from the filing by ALFA Finder's alert engine.
Kamdhenu Ltd: key numbers
- Share price
- ₹34.84
- Market cap
- ₹982.1 Cr
- Revenue (annual)
- ₹763.4 Cr
- Net profit (annual)
- ₹78.35 Cr
- P/E (TTM)
- 10.8×Sector 16.7×
- Promoter holding
- 49.03%+0.00% QoQ
- FII holding
- 1.65%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Kamdhenu Ltd
All →Kamdhenu Investor Presentation: Key Takeaways
Q2 FY27 revenue Rs 215.0 Cr (+12.5% YoY) and PAT Rs 23.8 Cr (+27.3%); H1 FY27 PAT Rs 52.5 Cr (+30.8%). Debt-free franchise model. No explicit guidance.
Kamdhenu Results Update
Kamdhenu's H1 FY27 PAT rose 31% YoY to a record Rs 52.5 crore on 11% revenue growth. Q2 PAT rose 27% to Rs 24 crore.
Kamdhenu Q2 FY27 Results: Net Profit ₹23.8 Cr, Up 27.3% YoY
Kamdhenu Ltd reported revenue from operations of ₹215 Cr (+12.5% YoY) and net profit of ₹23.8 Cr (+27.3% YoY) for Q2 FY27.
- Key figure
- Net profit ₹23.8 Cr · +27.3% YoY
Kamdhenu Board Meeting Date
Kamdhenu Limited will hold a board meeting on October 28, 2026, to consider and approve its standalone unaudited quarterly financial results.
Kamdhenu Other Announcement
Kamdhenu Limited submitted a NIL report from its Registrar regarding physical share transfer requests re-lodged under the SEBI special window. No transfer requests were processed.
Kamdhenu Annual General Meeting
Kamdhenu Ltd held its 32nd Annual General Meeting on September 25, 2026. The company reviewed financial statements and various director-related resolutions as part of the proceedings.
Other credit rating announcements
All →Epigral Credit Rating
CRISIL revised Epigral's ratings to CRISIL AA/Stable (long-term) and CRISIL A1+ (short-term) on its bank facilities. The action covers Rs.1,050 Crore of rated bank loan facilities.
Mankind Pharma Credit Rating
CRISIL reaffirmed Mankind Pharma's AA+ rating on Rs.2,500 Crore of NCDs and withdrew ratings on Rs.2,500 Crore NCDs and Rs.1,500 Crore commercial paper. The rating action is dated October 29, 2026.
Lloyds Metals & Energy Credit Rating
Crisil Ratings reaffirmed Lloyds Metals' bank facilities at AA/Stable and A1+, with bank limits enhanced to ₹17,112 crore. It assigned AA/Stable to ₹2,400 crore and ₹1,550 crore of NCDs.
Ram Ratna Wires Credit Rating
CARE Ratings assigned and reaffirmed Ram Ratna Wires' bank facility ratings at CARE A-; Positive / CARE A2+ and revised outlook from Stable to Positive. The long-term bank facilities total Rs.1,046.45 Crore, with several facilities enhanced.
Adani Ports & Special Economic Zone Credit Rating
Fitch Ratings affirmed Adani Ports' Long-Term Foreign-Currency IDR and unsecured notes at 'BBB-' with a Stable outlook. The affirmation keeps the existing rating unchanged.
Capri Global Capital Credit Rating
India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.